content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation
and recommendation
Cesca Therapeutics, Inc (KOOL)
0.00
(0.00%)
content_middle
Cesca is a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics.
Its device division, ThermoGenesis, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology.
Cesca is also leveraging its proprietary AutoXpress® technology platform to develop an automated, functionally-closed CAR-TXpress platform that addresses cellular manufacturing needs in the immuno-oncology field.
Previous Close:
0.00
Open:
3.31
Bid:
3.35
Ask:
3.40
1yr Target Price:
2.00
Day's Range:
3.16 - 3.34
52wk Range:
0.00 - 0.00
Volume:
7977
Average Daily Volume:
92565
Market Capitalization:
0.00M
Trailing Annual Dividend Yield:
N/A
Shares Outstanding:
0.00M
content_right
- February 23, 2014 - 3:20pm
- January 27, 2014 - 9:30am | Financings
- January 21, 2014 - 9:31am | Research Notes
- January 8, 2014 - 9:25am | Research Notes
- December 23, 2013 - 5:04pm | Research Notes
- December 20, 2013 - 9:20am | IP & Patents
- November 16, 2013 - 6:54pm | Research Notes
- November 16, 2013 - 6:39pm | Research Notes
- October 31, 2013 - 10:02am | Research Notes
- October 15, 2013 - 11:54am | Research Notes
- August 9, 2013 - 11:07am | Out and About
- July 16, 2013 - 7:41am | Research Notes, Financings
- June 12, 2013 - 12:05am | Out and About
- May 16, 2013 - 8:16am | Earnings
- May 10, 2013 - 8:02am | Research Notes
- May 8, 2013 - 7:43pm | Out and About
- February 13, 2013 - 8:02am | Earnings
- October 25, 2012 - 7:55am | IP & Patents
- September 21, 2012 - 7:30am | Earnings
- September 19, 2012 - 12:51pm | Research Notes